Tedor Pharma is proud to introduce a bold, new brand identity. The identity is driving a holistic system of branding which includes everything from signage to ads to digital communications. We have already implemented the new look internally and are rolling it out to market immediately, beginning with print advertisements can be seen in Pharmaceutical Daily News, in conjunction with the AAPS Show, November 12-15, in San Diego. Front-page editorials, full-page inserts and back-cover features in PDN will debut our re-branding each day—in both electronic and print formats—and for those in attendance, our new look will be on-display at the Tedor Booth; #2540.

The new visual identity represents our objective to express our key differentiator: an end-to-end model of integrated processes, capabilities and expertise which fosters speed, thoroughness and versatility. The goal of the branding is to clarify the Tedor image and key messages to all of our constituent groups, including customers, strategic partners and potential employees.

This brand evolution follows other recent significant milestones, including a multimillion dollar investment to expand the multipurpose manufacturing capacity at our Cumberland, Rhode Island facility, and last year’s additions of Carl Wooten and Roger Martin to our leadership team as President/CEO and COO, respectively.

Wooten said the unveiling of the new brand is not only reflective of the tremendous growth and positive change Tedor is experiencing, but is also a symbol of our mantra, Momentum Matters. “Momentum in this generic industry is critical, and Momentum Matters supports one of our principles that getting to market early is winning in the Generics sector,” Wooten said. “Simply stated, through agility, intensity and specialization, we will take our clients through the complex drug development process quickly and competently.”

Tedor is appreciative of all of our partners and employees who have not only helped to roll out the new brand and marketing communications, but—more importantly—helped define the unique Tedor DNA that was the impetus and energy behind it.

For more information contact Roger Martin at 401-658-5219 or rmartin@tedor.com.

Contact Tedor Pharma

Start typing and press Enter to search